| Autor: |
Martinez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Comin Orce A; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Gomez Mugarza P; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Barriendos Sanz S; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Ortega Izquierdo E; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain. |
| Jazyk: |
angličtina |
| Zdroj: |
Translational cancer research [Transl Cancer Res] 2023 Apr 28; Vol. 12 (4), pp. 692-696. Date of Electronic Publication: 2023 Apr 06. |
| DOI: |
10.21037/tcr-23-131 |
| Abstrakt: |
Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-131/coif). JMT received payment or honoraria for lectures from Astra-Zeneca, Pharmamar, Merck, Clovis, MSD, GSK, and meeting travel expenses from Pharmamar, MSD, Merck, and served on advisory board of Pharmamar, Boehringer-Ingelheim, Deciphera, Eisai. EOI received Payment or honoraria for lectures from Ipsen, Pharmamar, Merck, Eisai, MSD, GSK, and meeting travel expenses form MSD, Merck, and served on advisory board of Eisai. The other authors have no conflicts of interest to declare. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
